Summarizing findings regarding immune mediators such as cytokines in SS, it was concluded that T-helper (Th)2 cytokines are predominant in an early phase of SS, whereas Th1 cytokines are associated with a later stage of the disease [19]. The gene discussed is NELFCD; the disease is synovial sarcoma.